While patients successfully claimed agency over decades, forces arrayed against them only grew more powerful.
Interwar medical consumerism originated in the popular success of 100,000,000 Guinea Pigs (1933) , by F. J. Schlink and Arthur Kallet. This best seller sparked interest in medical reform among recently installed New Dealers as well as the educated middle class. An extended congressional battle resulted in some expansion of the FDA's scope and powers; debates over Social Security brought medical benefits to national attention. Postwar medicine tacked decisively toward a free enterprise model, with the AMA and an ascendant business class both resolutely opposed to regulation or public health care, and committed to expanding markets with rising costs borne by the consumer. Tomes argues this dynamic "worked not to allay the worries of the skeptical patient but rather to reinforce the absolute authority of the physician" (p. 156), which came back to haunt professionals, when patients revolted in earnest against in the 1960s. Finally the latter third of the century witnessed multiple critiques of traditional medicine, generating "intense political arguments about the causes and symptoms of the 'sick society' and its 'sick care' system." The upshot was the erosion of physician authority and a "'revolt of the patients' that brought the concept of the patient as watchdog into the mainstream" (p. 252)
Tomes presents an even-handed account, noting that patients have long maintained unrealistic expectations of medicine, fueled in turn by advertising puffery. Weak and insufficient regulatory enforcement often undermined the laws promoting patient safety and medical health. And finally, medical professionals and the businesses of medicine too often met their patients' concerns with advertising and obfuscation instead of reliable information. Tomes's story reveals that the American system of profit-driven medicine has always been fundamentally at odds with achieving a healthier country. And no matter how well sold, that is a bitter pill. Blood Sugar is a highly readable account of the emergence and import of "metabolic syndrome," a biomedical category of risk designed to capture the dangers of stroke, heart disease, and diabetes posed by the combination of potentially pathological characteristics: high blood pressure, high blood sugar, abnormal cholesterol, and high waist circumference. Metabolic syndrome provides a fascinating window into contemporary racialized biomedical conceptualizations of risk, and Blood Sugar is the first sustained sociological analysis of it.
The book explores the "politics of metabolism," which author Anthony Ryan Hatch defines as "the ideas, social practices, and institutional relationships that govern the metabolic health of individuals and groups" (p. 7). These operate across a range of scales, from "government health-research institutions, pharmaceutical corporations, and professional medical associations" to "biochemicals, DNA, and prescription drugs" (p. 7). Hatch's evidence is drawn mainly from published medical journals, complemented by reflections on his own experiences and broader observations. One of the most distinctive features of the book is that Hatch weaves macroscopic and microscopic technoscientific accounts together with his own embodied experience as an African American man who has been living with diabetes since 1992. The analysis of all of these registers is theoretically informed, drawing on critical race theory, biomedicalization, and Foucauldian biopower.
Hatch's analysis is guided by three questions (p. 11). The first concerns the intellectual history of metabolic syndrome: "How did metabolic syndrome emerge as a new discourse in the politics of metabolism?" (p. 11). This is rendered as a Foucauldian genealogy rather than a progressive history. It includes fascinating stories of early statistically driven categories of risk, such as French physician Jean Vague's 1940s elaboration of the notion of "index of maculine differentiation" and its attendant "android obesity" as a metacategory of risk for both heart disease and diabetes (pp. 46-48), and American physician Gerald Reaven's 1988 coining of a metacategory of risk driven by insulin insensitivity, the melodramatically named "Syndrome X" (pp. 52-55).
Hatch's second question is fundamentally epistemological: "How are current conceptions and meanings of race constructed through the science of metabolic syndrome?" (p. 11). This scientific racial construction comes to the fore in an incisive chapter provocatively titled "The Scientific Racism of Metabolism" (pp. 61-75). Hatch explores such issues as the problem of defining "ethnicity" as a "cause" of metabolic problems (p. 61). This component complements other recent scholarship in race and medicine that has explored other specific physiological and disease states, such as lung capacity, cancer, schizophrenia, and heart disease.
Hatch's third question extends his analysis beyond the spheres of scientific medicine: "What are the implications of this emerging relationship between metabolic syndrome and race for understanding the construction of racial meanings and the reproduction of racism within the politics of metabolism?" (p. 11). This becomes a route into discussing the broader issues of "food justice in Black America," promised in the book's subtitle. Hatch discusses both the brutal origin of African Americans' relationship with sugar, since sugar was an important cash crop in slave economies (p. 100), and the context of the contemporary relationships between race, social class, transnational food corporations, and neoliberal capitalism (p. 106). This leads to some of the book's most interesting synthetic analysis, across questions of food and pharmaceuticals: "the economic interests of agricultural and pharmaceutical corporations operate in our very bodies and shape the politics of metabolism in ways that go beyond posing food and drugs as disconnected political issues" (p. 107).
The book closes with "prescriptions," including calls for a "boycott of all foods that require laboratories, scientists, and factories for their mass production," and a call to "become . . . better educated about the potential benefits and real dangers of all pharmaceuticals compared to nonpharmaceutical forms of healing and wellness" (p. 119). Hatch argues that this should not be reduced to policing individual-level food choices, however, and that "we need to scrutinize and criticize the systems of choices for food and healing presented to us through the politics of metabolism" (p. 120). These are not altogether satisfying solutions for the deeply entrenched problems that the book has described, but perhaps that's fitting. Blood Sugar will be of interest to scholars across academic fields and even to nonscholarly readers, but there will be no easy answers.
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Most scholars agree that the shift from international health (IH) to global health (GH) marks a rupture in the history of world health. A prominent feature of this rupture has been the shift from the twentieth-century commonplace that states are the best guarantors of world health toward the suggestion that humanity's health is best cared for by "global" rather than national or international nonstate institutions.
A challenge that goes along with this turn to the global is this: How one can actually know-construct-a genuinely global, postnational humanity?
One answer to this question is metrics. For GH agencies, metrics are a tool to transform different, often unrelated local circumstances of disease into comparable "global numbers." They allow us to assess which disease causes how many life-years to be lost in what parts of the worlds; to come up with a priority list of diseases to be tackled; to measure the success of a given health intervention; and to determine which programs ought to be scaled up.
However, there is nothing self-evident about metrics. To produce metrics, one needs the expertise and infrastructure necessary to produce numbers. Consequently, GH institutions tend to couple grants they provide to infrastructural demands. Many GH institutions require their recipients to count money spent, people treated, meds given, life-years saved, deaths.
Metrics: What Counts in Global Health, edited by Vincanne Adams, is a splendid collection of essays by anthropologists and sociologists who map the effects a metrics-obsessed GH has on different sites, mostly in Africa. The book is composed of an introduction, eight ethnographic "on-the-ground" studies, and a brief epilogue.
